Global Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel Market Insights, Forecast to 2034
Sodium hyaluronate is the sodium salt of hyaluronic acid. Sodium hyaluronate, as a glycosaminoglycan, exists in the extracellular matrix of many connective tissues and the cornea in the human body. It is composed of D-glucuronic acid and N-acetyl-D-glucosamine. Artificial extraction of Streptococcus epidemics fermentation broth. Sodium hyaluronate and its solution are mostly used in ophthalmology and orthopedic surgery, providing support for surgical instruments and providing lubrication and cushioning for soft tissue joints. It is also widely used for beauty purposes, and is added to various cosmetics to improve the skin's water retention effect and relieve wrinkles.
Global Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel market is expected to reach to US$ 679.3 million in 2024, with a positive growth of %, compared with US$ 652.4 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel industry is evaluated to reach US$ 866 million in 2029. The CAGR will be 4.1% during 2024 to 2029.
Globally, Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel key manufacturers include B. Braun Melsungen, CryoLife, GluStitch, Ethicon, Chemence, Bausch & Lomb-Freda, Scapa Healthcare, Bostik and Henkel AG & Company, etc. B. Braun Melsungen, CryoLife, GluStitch are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel market and estimated to attract more attentions from industry insiders and investors.
Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel can be divided into 0.25ml/Stem, 0.5ml/Stem, 0.75ml/Stem and 1ml/Stem, etc. 0.25ml/Stem is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel is widely used in various fields, such as Eye Surgery, Orthopedic Surgery, Intra-articular Injection and Gynecological Surgery, etc. Eye Surgery provides greatest supports to the Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel industry development. In 2022, global % sales of Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel went into Eye Surgery filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
B. Braun Melsungen
CryoLife
GluStitch
Ethicon
Chemence
Bausch & Lomb-Freda
Scapa Healthcare
Bostik
Henkel AG & Company
Meyer-Haake Gmbh
Baxter International
Cyberbond
Segment by Type
0.25ml/Stem
0.5ml/Stem
0.75ml/Stem
1ml/Stem
1.25ml/Stem
1.5ml/Stem
Others
Eye Surgery
Orthopedic Surgery
Intra-articular Injection
Gynecological Surgery
Cosmetic Surgery
Others
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel plant distribution, commercial date of Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel introduction, etc. Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel market is expected to reach to US$ 679.3 million in 2024, with a positive growth of %, compared with US$ 652.4 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel industry is evaluated to reach US$ 866 million in 2029. The CAGR will be 4.1% during 2024 to 2029.
Globally, Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel key manufacturers include B. Braun Melsungen, CryoLife, GluStitch, Ethicon, Chemence, Bausch & Lomb-Freda, Scapa Healthcare, Bostik and Henkel AG & Company, etc. B. Braun Melsungen, CryoLife, GluStitch are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel market and estimated to attract more attentions from industry insiders and investors.
Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel can be divided into 0.25ml/Stem, 0.5ml/Stem, 0.75ml/Stem and 1ml/Stem, etc. 0.25ml/Stem is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel is widely used in various fields, such as Eye Surgery, Orthopedic Surgery, Intra-articular Injection and Gynecological Surgery, etc. Eye Surgery provides greatest supports to the Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel industry development. In 2022, global % sales of Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel went into Eye Surgery filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
B. Braun Melsungen
CryoLife
GluStitch
Ethicon
Chemence
Bausch & Lomb-Freda
Scapa Healthcare
Bostik
Henkel AG & Company
Meyer-Haake Gmbh
Baxter International
Cyberbond
Segment by Type
0.25ml/Stem
0.5ml/Stem
0.75ml/Stem
1ml/Stem
1.25ml/Stem
1.5ml/Stem
Others
Segment by Application
Eye Surgery
Orthopedic Surgery
Intra-articular Injection
Gynecological Surgery
Cosmetic Surgery
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel plant distribution, commercial date of Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel introduction, etc. Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Pharmaceutical Grade Non-animal-derived Sodium Hyaluronate Gel
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices